Antibody-mediated cell entry of SARS-CoV-2
M. G. Kibria, C. L. Lavine, W. Tang, S. Wang, H. Gao, W. Shi, H. Zhu, J. Voyer, S. Rits-Volloch, F. Keerti, C. Bi, H. Peng, D. Wesemann, J. Lu, H. Xie, , B. Chen
This study shows that certain monoclonal antibodies can replace ACE2 to mediate SARS-CoV-2 entry into cells, indicating that ACE2 is not essential for viral infection.
bioRxiv · Feb 20, 2023 · PreprintMicrobiology